India has called for extended collaboration in biotech start-ups and vaccine development with a public-private partnership for global good.

Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr. Jitendra Singh, presented India's first national repository for life science data collected by publically funded research.

India has a target of US$ 300 billion in bioeconomy by 2030 as the number of biotech firms in the nation is rising, according to Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr. Jitendra Singh.

India's bioeconomy is expected to touch US$ 150 billion by 2025 and over US$ 300 billion by 2030, according to a report by the Biotechnology Industry Research Assistance Council (BIRAC).

The Indian biotech sector is projected to increase to US$ 150 billion in the next four years from the current size of US$ 70 billion, as per Union Minister of State Science & Technology; Minister of State Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space Dr. Jitendra Singh.